0 of 7 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 7 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. How confident are you in the management of patients with AD in your practice?
2. Which characteristic must be present for a diagnosis of AD?
3. Ann is a 26-year-old female with moderate AD who presents for a regularly scheduled visit. She is currently managed with a medium potency TCS. Which of the following should be completed to assess the current impact of AD on her quality of life?
4. In moderate AD, which treatments do guidelines recommend for maintenance?
5. While best known for its cutaneous manifestations, AD is known to be a disease involving immune dysregulation causing an inflammatory cascade and overproduction of cytokines. Dupilumab addresses the underlying pathophysiology by targeting:
6. Hannah, a 16-year-old high school junior, has AD lesions on her face and excoriated lesions on flexural areas. She has a long history of AD and the disease is now less responsive to topical corticosteroids. Because of the pruritus, she has difficulty sleeping and focusing in school. Could she be a candidate for biologic AD therapy?
7. While all of the options below might be good reasons to refer an AD patient to a specialist, which one is stipulated by guidelines? An AD patient should be referred to a specialist when he or she: